The development of MHC peptide tetramers has allowed to visualize antigen-specific T-cell immunity in humans and in animal model systems. Monitoring T cell responses is now possible in a wide range of infectious diseases as well as in cancer research, transplantation immunology and vaccine development.

• Quantification of antigen-specific cytotoxic T-cells.
• MHC-Tetramer technology for monitoring of vaccine studies.